ENDLOS-TURBO PUT - AMGEN | Market Closed - Deutsche Boerse AG 01:04:49 08/06/2024 am IST | ||
| 6.61 EUR | +3.12% |
|
| Current month | -1.34% | ||
| 1 month | -9.33% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 07/24/07 | 6.61 | +3.12% |
| 06/24/06 | 6.41 | +0.94% |
| 05/24/05 | 6.35 | +0.79% |
| 04/24/04 | 6.3 | -0.47% |
| 03/24/03 | 6.33 | -5.52% |
Delayed Quote Deutsche Boerse AG
Last update June 08, 2024 at 01:04 am IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ2U7T |
| ISIN | DE000DJ2U7T8 |
| Date issued | 02/10/2023 |
| Strike | 376.1 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 10.23 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.27 € |
|---|---|
| Lowest since issue | 4.65 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305
USD
Average target price
316.3
USD
Spread / Average Target
+3.69%
- Stock Market
- Certificates
- Certificat
